Hematologists' perspective on advance directives, a French national cross-sectional survey - the ADORE-H study. [PDF]
Serey K+7 more
europepmc +1 more source
"SpezPat"- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians' understanding of non-small cell lung cancer patients' end-of-life decisions. [PDF]
Koenig JFL+6 more
europepmc +1 more source
Survey on Preferences Towards Advance Directives in Korean Adults
Soon-Yi Kim, Mee-Ae LEE, Shinmi Kim
openalex +2 more sources
The Texas Advance Directives Act of 1999: An Exercise in Futility? [PDF]
David M. Zientek
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp+13 more
wiley +1 more source
The instrumental value of advance directives: lesson learned from the COVID-19 pandemic for policymaking. [PDF]
Stock E, Nickel CH, Elger BS, Martani A.
europepmc +1 more source
Advance Directives and Consent to Organ Donation in Seven University Hospitals in North Rhine-Westphalia-a Retrospective, Multicenter Analysis. [PDF]
Englbrecht JS+6 more
europepmc +1 more source
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald+18 more
wiley +1 more source